Patent application number | Description | Published |
20120181442 | Device And Method For Measuring An Energy Particle Beam - The present invention relates to a dosimetry device for an energy particle beam from a source and including at least two ionization chambers, each of which includes a collector electrode and a polarization electrode, said electrodes in each ionization chamber being separated by a gap including a fluid, an energy beam from a single source passing through said ionization chambers, the device being characterized in that said ionization chambers have different charge collection efficiency factors. Said calculation algorithm for the dose rate deposited by said beam is based on the measurement of an output signal in each ionization chamber of the device and on a gain factor related to a first ionization chamber, said gain factor being theoretically predetermined on the basis of said intrinsic and/or extrinsic parameters of said ionization chambers. | 07-19-2012 |
20140061493 | Apparatus For Particle Therapy Verification - The invention is related to an apparatus and method for charged hadron therapy verification by detecting and/or quantifying prompt gammas produced when irradiating a target ( | 03-06-2014 |
20140145088 | Method And Apparatus For Particle Beam Range Verification - The invention is related to a method and apparatus for verifying the beam range in a target irradiated with a charged hadron beam, such as a proton beam. The beam range is the location of the Bragg peak in the target, being the location where the largest portion of the dose is delivered. The method utilizes a prompt gamma camera provided with a slit-shaped opening, so as to be able to produced a 1-dimensional profile of the dose distribution along the beam line. The camera is mounted with the slit oriented perpendicularly to the beam line. The method comprises the steps of calculating a position of the camera with respect to a target, for a plurality of beam energies and spots to be irradiated. The method further comprises the steps of verifying the beam range for said plurality of spots, and delivering a value representative of the difference between the estimated beam range and the actual beam range. The apparatus of the invention is provided with a positioning module for positioning the camera. | 05-29-2014 |
20150087882 | METHOD AND APPARATUS FOR MONITORING THE RANGE OF A PARTICLE BEAM - The invention is related to a method for monitoring a range of a particle beam in a target. The method is using gamma detectors for detecting prompt gammas produced in the target. The time differences between the time of detecting a gamma quantum and a time of emission of a particle or a bunch of particles from the radiation device are determined. A statistical distribution of those time difference is used to deduce information related to the range of the beam. The invention is also related to an apparatus for monitoring a range based on measured time profiles of detected prompt gammas. | 03-26-2015 |
Patent application number | Description | Published |
20090162394 | VACCINE - The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent | 06-25-2009 |
20100119544 | VACCINE - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from | 05-13-2010 |
20100291138 | Vaccine - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form | 11-18-2010 |
20110217329 | Vaccine - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form | 09-08-2011 |
20110318407 | INACTIVATED DENGUE VIRUS VACCINE WITH ALUMINIUM-FREE ADJUVANT - The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus. | 12-29-2011 |
20120189654 | VACCINE - The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent | 07-26-2012 |
20130216614 | IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS - The present invention relates to methods and compositions for preventing and reducing amyloid deposition in a subject by administering to the subject a composition containing aTLR4 agonist free of endotoxin, where the composition does not contain beta amyloid. | 08-22-2013 |
20150079125 | VACCINE - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from | 03-19-2015 |
20150079129 | VACCINE - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from | 03-19-2015 |